by Kristen Monaco, Staff Writer, MedPage Today August 24, 2022
During the pandemic, new cases of type 2 diabetes increased by 77.2% among pediatric patients. “Whether the increase was caused by COVID-19 infection, or just associated with environmental changes and stressors during the pandemic is unclear,” researchers wrote in the Journal of Pediatrics.
More than a quarter of patients on desmopressin therapy for central diabetes insipidus had hyponatremia leading to hospitalization, according to a survey of 1,034 patients. (Lancet Diabetes & Endocrinology)
The Omnipod 5 Automated Insulin Delivery System was cleared by the FDA for use in kids ages 2 years and up with type 1 diabetes, Insulet announced. It was previously cleared for kids ages 6 and older.
The FDA granted fast track designation to the investigational drug SYNB1353 as a potential treatment for the rare metabolic condition homocystinuria, Synlogic announced.
AZD1656, an investigational glucokinase activator, flopped in the ARCADIA trial, failing to reduce the number of COVID deaths in hospitalized adults with diabetes versus placebo. (eClinicalMedicine)
Rep. Marjorie Taylor Greene (R-Ga.) introduced a bill that would make providing gender-affirming medical care to youth a felony punishable by up to 25 years in prison. (The Hill)
The FDA accepted Astellas Pharma’s new drug application for fezolinetant — an investigational oral nonhormonal treatment for moderate to severe vasomotor symptoms associated with menopause — with supporting data from the SKYLIGHT clinical program. The Prescription Drug User Fee Act target action date is Feb. 22, 2023.
A new study found that exposure to the endocrine disruptor glyphosate, most commonly found in the weed killer Roundup, was linked with convulsions in nematodes. (Scientific Reports)
A federal judge ruled that transgender individuals are protected against discrimination under the Americans with Disabilities Act. (The Hill)
Kristen Monaco is a staff writer, focusing on endocrinology, psychiatry, and nephrology news. Based out of the New York City office, she’s worked at the company since 2015.
The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider.
© 2022 MedPage Today, LLC. All rights reserved.
Medpage Today is among the federally registered trademarks of MedPage Today, LLC and may not be used by third parties without explicit permission.
Diabeets
11/10/2022